Literature DB >> 9119403

Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3.

H M Mitchison1, P B Munroe, A M O'Rawe, P E Taschner, N de Vos, G Kremmidiotis, I Lensink, A C Munk, K L D'Arigo, J W Anderson, T J Lerner, R K Moyzis, D F Callen, M H Breuning, N A Doggett, R M Gardiner, S E Mole.   

Abstract

We recently cloned a cDNA for CLN3, the gene for juvenile-onset neuronal ceroid lipofuscinosis or Batten disease. To resolve the genomic organization we used a cosmid clone containing CLN3 to sequence the entire gene in addition to 1.1 kb 5' of the start of the published CLN3 cDNA and 0.3 kb 3' to the polyadenylation site. CLN3 is organized into at least 15 exons spanning 15 kb and ranging from 47 to 356 bp. The 14 introns vary from 80 to 4227 bp, and all exon/intron junction sequences conform to the GT/AG rule. Numerous repetitive Alu elements are present within the introns and 5'- and 3'-untranslated regions. The 5' region of the CLN3 gene contains several potential transcription regulatory elements but no consensus TATA-1 box was identified. CLN3 is homologous to 27 deposited human ESTs, and sequence comparisons suggest alternative splicing of the gene and the existence of transcribed sequences upstream to the start of the published CLN3 cDNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119403     DOI: 10.1006/geno.1996.4576

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  A 12-Mb complete coverage BAC contig map in human chromosome 16p13.1-p11.2.

Authors:  Y Cao; H L Kang; X Xu; M Wang; S H Dho; J R Huh; B J Lee; F Kalush; D Bocskai; Y Ding; J G Tesmer; J Lee; E Moon; V Jurecic; A Baldini; H U Weier; N A Doggett; M I Simon; M D Adams; U J Kim
Journal:  Genome Res       Date:  1999-08       Impact factor: 9.043

2.  Spectrum of mutations in the Batten disease gene, CLN3.

Authors:  P B Munroe; H M Mitchison; A M O'Rawe; J W Anderson; R M Boustany; T J Lerner; P E Taschner; N de Vos; M H Breuning; R M Gardiner; S E Mole
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  J M Kwon; H Adams; P G Rothberg; E F Augustine; F J Marshall; E A Deblieck; A Vierhile; C A Beck; N J Newhouse; J Cialone; E Levy; D Ramirez-Montealegre; L S Dure; K R Rose; J W Mink
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

4.  Rapid detection of the major deletion in the Batten disease gene CLN3 by allele specific PCR.

Authors:  P E Taschner; N de Vos; M H Breuning
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

Review 5.  Safeguarding Lysosomal Homeostasis by DNAJC5/CSPα-Mediated Unconventional Protein Secretion and Endosomal Microautophagy.

Authors:  Juhyung Lee; Yue Xu; Yihong Ye
Journal:  Front Cell Dev Biol       Date:  2022-05-10

6.  An unusual clinical severity of 16p11.2 deletion syndrome caused by unmasked recessive mutation of CLN3.

Authors:  Céline Pebrel-Richard; Anne Debost-Legrand; Eléonore Eymard-Pierre; Victoria Greze; Stéphan Kemeny; Mathilde Gay-Bellile; Laetitia Gouas; Andreï Tchirkov; Philippe Vago; Carole Goumy; Christine Francannet
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

7.  Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease.

Authors:  Christopher J Minnis; StJohn Townsend; Julia Petschnigg; Elisa Tinelli; Jürg Bähler; Claire Russell; Sara E Mole
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

8.  Analysis of NCL Proteins from an Evolutionary Standpoint.

Authors:  Neda E Muzaffar; David A Pearce
Journal:  Curr Genomics       Date:  2008-04       Impact factor: 2.236

Review 9.  The CLN3 gene and protein: What we know.

Authors:  Myriam Mirza; Anna Vainshtein; Alberto DiRonza; Uma Chandrachud; Luke J Haslett; Michela Palmieri; Stephan Storch; Janos Groh; Niv Dobzinski; Gennaro Napolitano; Carolin Schmidtke; Danielle M Kerkovich
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.